Adenosine modulators and calcium channel blockers as add-on treatment for schizophrenia
Abstract Relapses remain common among individuals with schizophrenia indicating a need for improved treatments. Creating a completely new drug molecule is expensive and time consuming, and therefore drug repurposing should be considered. Aim of this study was to investigate the risk of psychiatric r...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-01-01
|
Series: | npj Schizophrenia |
Online Access: | https://doi.org/10.1038/s41537-020-00135-y |